Literature DB >> 831126

The sympathetic-nervous-system defect in primary orthostatic hypotension.

M G Ziegler, C R Lake, I J Kopin.   

Abstract

We sought to elucidate further the neurologic defect of idiopathic orthostatic hypotension, which appears to represent two distinct clinical entities. While recumbent, patients with multiple central-nervous-system defects, as well as peripheral autonomic nervous dysfunction, have normal plasma levels of norepinephrine that fail to increase normally after standing or exertion (P less than 0.001 by t-test as compared to controls). While recumbent, patients with peripheral autonomic insufficiency without signs of central-nervous-system defects have low levels of plasma norepinephrine (P less than 0.001) that also fail to increase normally after standing or exercising (P less than 0.001). Both groups have low levels of plasma dopamine-beta-hydroxylase (P less than 0.02). These findings are consistent with other pathological and pharmacologic observations suggesting that patients with central-nervous-system disease are unable to activate appropriately an otherwise intact sympathetic nervous system, whereas in patients without signs of central-nervous-system disease the deficit affects peripheral sympathetic nerves.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 831126     DOI: 10.1056/NEJM197702102960601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  66 in total

Review 1.  Multiple system atrophy: pathophysiology and management.

Authors:  G K Wenning; S Braune
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Sympathetic neurocirculatory failure in Parkinson disease: Evidence for an etiologic role of alpha-synuclein.

Authors:  D S Goldstein; S T Li; I J Kopin
Journal:  Ann Intern Med       Date:  2001-12-04       Impact factor: 25.391

Review 3.  Multiple system atrophy.

Authors:  H U Rehman
Journal:  Postgrad Med J       Date:  2001-06       Impact factor: 2.401

Review 4.  Dysautonomia: perioperative implications.

Authors:  Hossam I Mustafa; Joshua P Fessel; John Barwise; John R Shannon; Satish R Raj; André Diedrich; Italo Biaggioni; David Robertson
Journal:  Anesthesiology       Date:  2012-01       Impact factor: 7.892

5.  Improvement of the exercise capacity of a patient with primary orthostatic hypotension (primary sympathetic insufficiency) by programmed subcutaneous noradrenaline administration via microdosing pump.

Authors:  M Lehmann; K G Petersen; A N Khalaf; D Häussinger; C Büchner; M Sellinger; K Peter
Journal:  Klin Wochenschr       Date:  1990-09-03

6.  Beta-adrenergic blood pressure regulation in Shy-Drager syndrome and pheochromocytoma.

Authors:  M Middeke; J Ittner; M Mezger; S Reder; J Remien
Journal:  Klin Wochenschr       Date:  1989-10-02

Review 7.  Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome.

Authors:  N Sodhi; M Camilleri; J K Camoriano; P A Low; R D Fealey; M C Perry
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

Review 8.  Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension.

Authors:  Ahmed Elgebaly; Bassant Abdelazeim; Omar Mattar; Mohamed Gadelkarim; Rehab Salah; Ahmed Negida
Journal:  Clin Auton Res       Date:  2016-03-07       Impact factor: 4.435

9.  Cholinergic stimulation of norepinephrine release in man. Evidence of a sympathetic postganglionic axonal lesion in diabetic adrenergic neuropathy.

Authors:  S A Leveston; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

Review 10.  The heart in diabetes.

Authors:  D J Kereiakes; J L Naughton; B Brundage; N B Schiller
Journal:  West J Med       Date:  1984-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.